Eli Lilly and Company (NYSE:LLY), a United States-based pharmaceutical company, announced on Friday the retirement of Philip Johnson from the position of group vice president and treasurer.
Johnson is retiring from the company at the end of February to pursue a new professional opportunity. The successor to Johnson will be revealed at a future date.
Johnson headed the company's investor relations group for 11 years and was consistently named Top Investor Relations Officer by Institutional Investor. He worked as the company's treasurer since 2018 and has headed the firm's efforts within the financial community to drive positive social and economic change for underrepresented groups.
Neuspera Medical names new chief operating officer
GenScript Biotech Corporation names new board members
Alchemab Therapeutics names new CEO
Breg names new chief executive officer and chief financial officer
Rivus Pharmaceuticals names new CFO and independent member of board of directors